[ET Net News Agency, 12 August 2021] INNOCARE-B (09969) fell 9.42% to HK$22.6, dipping
below the 100-D SMA of HK$24.192.
It hits an intra-day low of HK$22.45, and an intra-day high of HK$24.55. The total
shares traded was 4.82 million, with a value of HK$112.48m. The active buy/sell ratio is
41:59, with net selling turnover of HK$19.97m. MERRILL LYNCH FE accounts for greatest net
responsive buying turnover of HK$5.77m, with volume weighted average price of HK$23.427.
HSBC SEC BRO (ASIA) accounts for greatest net responsive selling turnover of HK$9.11m,
with volume weighted average price of HK$23.578. The stock has fallen a combined 11.2%
over the past 2 consecutive trading days.
The Hang Seng Index now fell 144 points, or 0.54% to 26,516; the Hang Seng China
Enterprises Index now fell 73 points, or 0.77% to 9,474; the Hang Seng TECH Index now fell
96 points, or 1.41% to 6,724; with an overall turnover of HK$86.48b.
The SSE Composite Index now fell 7 points, or 0.2% to 3,525, with an overall turnover of
RMB406.91b.
The SZSE Component Index now fell 98 points, or 0.65% to 14,923, with an overall
turnover of RMB271.95b.

Basic Information
-------------------------------------------
Nominal 22.600 % Chg -9.42%
High 24.550 Low 22.450
Shares Tr 4.82m Turnover 112.48m
10-D SMA 24.805 %H.V 63.885
20-D SMA 26.195 VWAP 23.316
50-D SMA 26.541 RSI14 35.895
-------------------------------------------
Status: Dipping below the 100-D SMA, active buy/sell ratio is 41:59, with net selling
turnover of HK$19.97m, falling a combined 11.2% over the past 2 consecutive
trading days

Table: Performance of stocks in the same sector or of relevance

Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
INNOCARE-B (09969) 22.60 -9.42
GENSCRIPT BIO (01548) 34.35 -3.24
INNOVENT BIO (01801) 70.40 -4.99
JXR (01951) 13.60 -3.27
BRII-B (02137) 35.70 -10.75
WUXI BIO (02269) 119.60 -3.16
BEIGENE (06160) 165.80 -6.27
CANSINOBIO-B (06185) 301.00 -8.23
AKESO-B (09926) 44.30 -6.93
REMEGEN-B (09995) 114.00 -6.25
-------------------------------------------------
(ed)